Full Text
The Full Text of this article is available as a PDF (256.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Albertsen P. C., Fryback D. G., Storer B. E., Kolon T. F., Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA. 1995 Aug 23;274(8):626–631. [PubMed] [Google Scholar]
- Brawley O. W. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer. 1997 Nov 1;80(9):1857–1863. doi: 10.1002/(sici)1097-0142(19971101)80:9<1857::aid-cncr26>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-1985. Progressive pneumonitis after chemotherapy for breast carcinoma. N Engl J Med. 1985 Feb 7;312(6):359–369. doi: 10.1056/NEJM198502073120608. [DOI] [PubMed] [Google Scholar]
- Catalona W. J. Screening for prostate cancer. JAMA. 1995 Apr 19;273(15):1174–1176. doi: 10.1001/jama.273.15.1174. [DOI] [PubMed] [Google Scholar]
- Chodak G. W., Thisted R. A., Gerber G. S., Johansson J. E., Adolfsson J., Jones G. W., Chisholm G. D., Moskovitz B., Livne P. M., Warner J. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994 Jan 27;330(4):242–248. doi: 10.1056/NEJM199401273300403. [DOI] [PubMed] [Google Scholar]
- Coley C. M., Barry M. J., Fleming C., Fahs M. C., Mulley A. G. Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians. Ann Intern Med. 1997 Mar 15;126(6):468–479. doi: 10.7326/0003-4819-126-6-199703150-00010. [DOI] [PubMed] [Google Scholar]
- Helgesen F., Holmberg L., Johansson J. E., Bergström R., Adami H. O. Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst. 1996 Sep 4;88(17):1216–1221. doi: 10.1093/jnci/88.17.1216. [DOI] [PubMed] [Google Scholar]
- Krahn M. D., Mahoney J. E., Eckman M. H., Trachtenberg J., Pauker S. G., Detsky A. S. Screening for prostate cancer. A decision analytic view. JAMA. 1994 Sep 14;272(10):773–780. [PubMed] [Google Scholar]
- Kushwaha S. S., Narula J., Narula N., Zervos G., Semigran M. J., Fischman A. J., Alpert N. A., Dec G. W., Gewirtz H. Pattern of changes over time in myocardial blood flow and microvascular dilator capacity in patients with normally functioning cardiac allografts. Am J Cardiol. 1998 Dec 1;82(11):1377–1381. doi: 10.1016/s0002-9149(98)00645-6. [DOI] [PubMed] [Google Scholar]
- Lu-Yao G. L., Yao S. L. Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet. 1997 Mar 29;349(9056):906–910. doi: 10.1016/S0140-6736(96)09380-4. [DOI] [PubMed] [Google Scholar]
- Middleton R. G. Prostate cancer: are we screening and treating too much? Ann Intern Med. 1997 Mar 15;126(6):465–467. doi: 10.7326/0003-4819-126-6-199703150-00009. [DOI] [PubMed] [Google Scholar]
- Miles B. J., Kattan M. W., Giesler R. B., Cowen M. Screening for prostate cancer. JAMA. 1995 Apr 19;273(15):1173–1176. doi: 10.1001/jama.1995.03520390031018. [DOI] [PubMed] [Google Scholar]
- Sackett D. L., Holland W. W. Controversy in the detection of disease. Lancet. 1975 Aug 23;2(7930):357–359. doi: 10.1016/s0140-6736(75)92790-7. [DOI] [PubMed] [Google Scholar]
- Smith D. S., Catalona W. J., Herschman J. D. Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA. 1996 Oct 23;276(16):1309–1315. [PubMed] [Google Scholar]
- Wiktor Z., Jacyszyn K., Kaplicki M., Samsonowicz-Dec J. Das Verhalten der Plasmaelektrolytkonzentration bei der Pyelonephritis chronica. Z Gesamte Inn Med. 1965 Oct 1;20(19 Suppl):159–c. [PubMed] [Google Scholar]
- Woolf S. H. Should we screen for prostate cancer? BMJ. 1997 Apr 5;314(7086):989–990. doi: 10.1136/bmj.314.7086.989. [DOI] [PMC free article] [PubMed] [Google Scholar]